![]() trans-4-Aminocyclohexanol hydrochloride (1:1) structure
|
Common Name | trans-4-Aminocyclohexanol hydrochloride (1:1) | ||
---|---|---|---|---|
CAS Number | 50910-54-8 | Molecular Weight | 151.635 | |
Density | N/A | Boiling Point | 201.1ºC at 760mmHg | |
Molecular Formula | C6H14ClNO | Melting Point | 225-227 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 75.4ºC | |
Symbol |
![]() GHS07 |
Signal Word | Warning |
The precursor strategy: terminus methoxyoxalamido modifiers for single and multiple functionalization of oligodeoxyribonucleotides.
Nucleic Acids Res. 28(16) , 3125-33, (2000) Synthesis of new terminus modifiers, bearing, along with a phosphoramidite moiety, one, two or four methoxyoxalamido (MOX) precursor groups, is described. These modifiers are introduced onto the 5'-end of a synthetic oligodeoxyribonucleotide as the last step ... |
|
Domino synthesis of bridged bicyclic tetrahydro-1,2-oxazines: access to stereodefined 4-aminocyclohexanols.
Org. Lett. 11(16) , 3694-7, (2009) The intramolecular variant of the homo-[3 + 2]-dipolar cycloaddition of nitrones (generated in situ from an aldehyde and a hydroxylamine) with donor-acceptor cyclopropanes allows for the efficient synthesis of bridged tetrahydro-1,2-oxazines. This domino sequ... |
|
The morphogenesis of cyclohexylamine-induced testicular atrophy in the rat: in vivo and in vitro studies.
Exp. Mol. Pathol. 52(2) , 155-69, (1990) Male Wistar strain rats were fed a diet providing an intake of 0 or 400 mg cyclohexylamine (CHA)/kg body weight/day for 1, 3, 7, 9, or 13 weeks. At the end of the appropriate feeding period the rats were perfused-fixed with Karnovsky's fixative. The weights o... |
|
Synthesis and microbial hydroxylation of some azabicycloalkanes. Olivo HF, et al.
Tetrahedron Lett. 39(11) , 1309-12, (1998)
|
|
Polybenzoxazine-silica (PBZ-SiO2) hybrid nanocomposites through in situ sol-gel method. Devaraju S, et al.
J. Sol-Gel Sci. Technol. 60(1) , 33-40, (2011)
|
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved